echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Total denial! Boya Bio Responds to Shenzhen Stock Exchange Inquiry "The Company Has No Actual Controller"

    Total denial! Boya Bio Responds to Shenzhen Stock Exchange Inquiry "The Company Has No Actual Controller"

    • Last Update: 2020-11-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 14, Boya Bio issued an announcement to formally respond to the Shenzhen Stock Exchange's previous inquiries.
    September 4th, the gem company management department of Shenzhen Stock Exchange sent an inquiry letter to Cai Dajian, chairman of the Gotejia Group, which controls Boya Bio.
    inquiry about the relationship between Cai Dajian and Gautejia, which directly asked "Do you (Cai Dajian) actually control Boya's creatures".
    in public information, The Post said its controlling shareholder, Gauteja, had "no actual controllers."
    the announcement, Boya Bio's four-point inquiry into The Deep Cross was all denied.
    just days before Boya's response, an "open letter to every Gaute" went viral in the industry.
    , the author of the open letter, who identified herself as Cai Dajian's wife, referred to Cai as "the controlling shareholder of Gautja" in addition to accusing him of cheating and the divorce dispute between the two men.
    letter also questioned Cai Dajian's inability to devote energy to his work due to the derailment,
    inseconding Gottja's management so far in 2017 and causing major mergers and acquisitions to spiral out of control (such as the Danxia project).
    a clarification announcement issued on September 11th,
    said that Gauteja and Boya Bio "remain independent of each other" and that "Gauteja Group and Cai Dajian do not participate in the company's business activities".
    01 Real controller suspect cloud outside of the Boya biological "whether there is a real controller" question has long begun.
    inquiry letter to Boya Bio's 2019 annual report, SSE requested the company to "screen and give evidence on the absence of an actual controller of the listed company, and to have a clear opinion from an independent director".
    In its response on June 2, Boa Bio said that the controlling shareholder of the company is Shenzhen Gaotejia Investment Group Co., Ltd., The equity structure of The Goethia Group is relatively dispersed, no shareholders can directly or indirectly or jointly control the Gautja Group, Goethia Group has no controlling shareholders, no actual controller.
    ", the company has no actual controllers.
    " was also endorsed by the company's independent directors.
    , which dominates the domestic blood products, was founded in 1993.
    2007, Cai Dajian, chairman of Gautejia, bought an 85% stake in Jiangxi Boya for 102 million yuan.
    was successfully listed on the Shenzhen GEM in 2012 under the operation of Gautejia.
    's significance to Boya's creatures is self-evident.
    answered the Shenzhen Stock Exchange's inquiries, Gautejia's real-controller doubts did not dissipate.
    add a bit of drama to the story by adding to the plot of "The Wife Tears Her Husband."
    According to sky-eye surveys, the ultimate beneficiaries of the three companies, Shenzhen Jiaxing and Run, Shenzhen Express and Shenzhen Sunshine Jiarun, which rank 2-4 among the controlling shareholders, are Cai Dajian.
    also named Cai Dajian as the "suspected actual controller" of three companies, which together account for 43.68 percent of the shares in Gauteja.
    other media reports, through a series of transfers of interests, the signing of a holding agreement and other means to occupy 7.5702 percent of the shares of Gaotejia Shenzhen Peninsula Bay is actually controlled by Cai Dajian.
    addition, Suzhou Gaote Jiaying, Xiamen Gaote Jiaying, Xiamen and Feng Jiarun also have Cai Dajian holdings.
    , just as the outside world increasingly questioned Cai Dajian's actual control of Gautejia, and then the actual control of Boya bio, Boya bio through the Shenzhen Stock Exchange's response to these questions "hit back."
    In its reply to the announcement, for Peninsula Bay, Cai Dajian acknowledged the existence and signed a holding agreement with Kejia, Huzhou (the transferant in the transfer of Shares in Peninsula Bay), but said that the signing of the agreement is only to ensure the smooth implementation of the transfer agreement, "I have no intention of continuing to increase the stake in the Gautja Group, nor is there any intention to control."
    Regarding the transfer of shares of Xiamen Gautejia, the announcement said that the "until today" agreement has not been signed and the relevant industrial and commercial changes have not been made, so Xiamen Gautejia has no actual controller, and Cai Dajian does not hold the shares of Xiamen Gautejia.
    announcement also denied any concerted action or voting rights mandate with any other directors, supervisors, senior management and shareholders of Boya Bio or Gauteja Group.
    In response to a shenzhen stock exchange's "Please explain whether you actually control Boya Bio", the company said in its response to the announcement that Gautejia is committed to making extensive investments in health care, "rather than focusing on acquiring and operating a physical enterprise", Cai Dajian also said that "my business focus and working hours are mainly focused on the investment business of The Gothia Group, management and business work is very large", and did not participate in the day-to-day operations of Boa Bio.
    's final announcement also made a statement to the controlling shareholders of Gaotejia, confirming only that the real controllers of Shenzhen Jiaxing and Run, Shenzhen Express and Shenzhen Sunshine Jiarun were Cai Dajian, but that other holding companies and controlling natural persons or no actual controllers, or no concerted action by other shareholders.
    "I am not the actual controller of Boao, nor is there any actual control of Boya." article 216, paragraph 3, of the Company Law,
    "02 Invisible Real Controller, stipulates that the actual controller means a person who is not a shareholder of the company but who, through investment relations, agreements or other arrangements, can actually control the conduct of the company.
    in short, the actual controller's control of the listed company also affects the interests of the whole company and all shareholders.
    the actual controller in the case of concealing the actual controller is very likely to use his identity to manipulate the listed company and do things that are detrimental to the interests of the listed company, so it is one of the key points of supervision.
    is no stranger to concealing the actual controller.
    last year, the four-ring creature was punished by the SFC for concealing the actual controller for up to five years.
    In 2017, the two major shareholders of Four Rings Bio, Guangzhou Shengjing and Deyuan Textiles, openly attacked each other, which evolved into mutual reporting and requests to initiate investigation procedures against each other, in which Guangzhou Shengjing initiated an investigation into whether Deyuan Textiles constituted a concerted actor.
    "infighting" at the same time attracted the attention of the SFC and stepped in to investigate.
    the confessions of those involved, a five-year-old "invisible" real controller surfaced.
    In 2019, the SFC finally found that Lu Keping owned control of 13 securities accounts and two equity instruments, including Deyuan Textiles, and the voting rights of the four-ring bio-shares they held, a practice in which Lu Keping has been the de facto controller of the four-ring organism since 2014, but has always claimed in public information that there is no actual controller.
    the four-ring creature was found to be concealing the identity of Lu Keping's real controller, but also found that it concealed the listed company and Lu Keping under the control of the enterprise's related transactions.
    's inquiries about Boya Bio also point to "questions about whether there are actual controllers", and on June 29th the Shenzhen Stock Exchange issued a letter of inquiry on Boya Bio pointing directly to its related transactions with Danxia Bio.
    according to the enquiry, three consecutive plasma purchase orders signed by Boya Bio and Danxia Bio in 2017, 2018 and 2019 failed to complete the plasma supply and the actual purchase amount was 0.
    , the SSE gave Boya Bio one day to explain whether the move was in line with industry practice and whether the controlling shareholders were occupying the company's non-operating funds, and disclosed the relevant disclosure materials.
    day later, Boya Bio replied that due to the scarcity of raw plasma, the company and Boya (Guangdong) signed the relevant procurement agreement in accordance with the agreement to arrange payment, so it is reasonable.
    only the procurement or transfer of plasma needs the special approval of the relevant state departments, "so far the procurement of raw material plasma has not been approved."
    it is worth mentioning that there are media reports in April 2017 Boya Bio issued an announcement that with Gautejia co-investment merger and acquisition fund former Haiyou, the manager is Gao Tejia.
    and the month before, Haiyou Hen paid 4.5 billion yuan for a 99% stake in Danxia Bio.
    have responded to the fact that boa live, the results will remain to be seen at a later date.
    but there may be more concerns than the actual controller."
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.